Chapter 9. Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism

  1. Mark A. Crowther MD, MSc, FRCPC Professor Division Director2,3,
  2. Jeff Ginsberg MD, FRCPC Professor4,
  3. Holger J. Schünemann MD, PhD, MSc, FACP, FCCP Professor5,6,
  4. Ralph M. Meyer MD, FRCPC Director Professor7,8 and
  5. Richard Lottenberg MD, FACP Professor9
  1. Sam Schulman MD, PhD, FRCPS

Published Online: 4 FEB 2009

DOI: 10.1002/9781444300857.ch9

Evidence-Based Hematology

Evidence-Based Hematology

How to Cite

Schulman, S. (2008) Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism, in Evidence-Based Hematology (eds M. A. Crowther, J. Ginsberg, H. J. Schünemann, R. M. Meyer and R. Lottenberg), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444300857.ch9

Editor Information

  1. 2

    Division of Hematology, McMaster University, Hamilton, Ontario, Canada

  2. 3

    St. Joseph's Hospital, Hamilton, Ontario, Canada

  3. 4

    Department of Medicine, McMaster University, Hamilton, Canada

  4. 5

    CLARITY Research Group, Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy

  5. 6

    McMaster University, Hamilton, Canada

  6. 7

    National Cancer Institute of Canada, Clinical Trials Group, Edith Eisenhauer Chair in Clinical Cancer Research, Queen's University, Kingston, Ontario, Canada

  7. 8

    Departments of Oncology and Medicine, Queen's University, Kingston, Ontario, Canada

  8. 9

    Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA

Author Information

  1. Clinical Thromboembolism Program, McMaster University, Hamilton, Ontario, Canada

Publication History

  1. Published Online: 4 FEB 2009
  2. Published Print: 27 JUN 2008

ISBN Information

Print ISBN: 9781405157476

Online ISBN: 9781444300857

SEARCH

Keywords:

  • initial therapy of deep vein thrombosis;
  • active initial treatment versus placebo in patients with deep vein thrombosis;
  • initial anticoagulant treatment - UFH and low-molecular-weight heparin (LMWH);
  • activated partial thromboplastin time (APTT);
  • optimal regimen for heparin;
  • secondary prophylaxis with vitamin K antagonists;
  • treating patients with VTE at home;
  • studies on DVT with or without early mobilization;
  • early mobilization, compression stockings in venous thromboembolism

Summary

This chapter contains sections titled:

  • Introduction

  • References